Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia, Inc. (NYSE: PHR) is a healthcare technology company focused on patient activation, digital intake, outreach and education for healthcare providers, life sciences companies and other organizations. The Phreesia news feed on Stock Titan highlights company announcements, financial updates and product developments that shape how it engages patients and supports healthcare workflows.
Investors and industry followers can use this page to review earnings releases and outlook updates, where Phreesia reports quarterly revenue, subscription and related services, payment processing fees, network solutions revenue and key metrics such as average healthcare services clients and revenue per client. These updates often include management commentary on operating leverage, cash flows and non-GAAP measures like Adjusted EBITDA.
The news stream also features transaction and financing disclosures, including details about the acquisition of AccessOne Parent Holdings, Inc., a provider of financing solutions for healthcare receivables, and related bridge loan and credit facility arrangements. These items are relevant for understanding Phreesia’s growth strategy and capital structure.
In addition, readers will find product and innovation news, such as the launch of Phreesia VoiceAI, an AI-driven phone solution for managing patient calls, and partnership and recognition stories, including the collaboration with Sesame Workshop and inclusion in rankings like the Deloitte Technology Fast 500™ and Capterra Shortlists. Bookmark this page to follow how Phreesia communicates its performance, platform enhancements and strategic initiatives over time.
Phreesia, Inc. (NYSE: PHR) has closed an underwritten public offering of 5,750,000 shares of its common stock, including an additional 750,000 shares purchased through underwriters' options. The shares were priced at $32.00 each, yielding net proceeds of approximately $174.4 million after expenses. The offering was managed by J.P. Morgan and William Blair, among others. A prospectus supplement has been filed with the SEC, outlining the terms. Phreesia's platform enhances patient intake for healthcare organizations, improving efficiency and clinical care.
Phreesia, Inc. (NYSE:PHR) has priced its public offering of 5,000,000 shares of common stock at $32.00 per share, with a potential net proceeds of approximately $151.6 million, or $174.4 million if underwriters exercise their option for 750,000 additional shares. The offering is expected to close on October 23, 2020, subject to customary conditions. J.P. Morgan and William Blair serve as joint book-running managers. The offering's details are available via a prospectus supplement filed with the SEC.
Phreesia, Inc. (NYSE: PHR) has launched an underwritten public offering of 5,000,000 shares of its common stock, with an option for underwriters to acquire an additional 750,000 shares. The offering is subject to market conditions, and its completion is not guaranteed. J.P. Morgan and William Blair serve as joint book-running managers. The offering is registered under an automatic shelf registration statement with the SEC, and further details will be provided in a prospectus supplement. Phreesia provides a comprehensive patient intake management platform for healthcare organizations.
Phreesia has acquired two innovative web-based workflow applications co-developed by Geisinger and Merck, aimed at enhancing patient care and communication. The Family Caregiver application promotes coordination for oncology patients, while MedTrue™ assists in medication reconciliation. These applications will be integrated into Phreesia's existing electronic health record systems, supporting the company's mission to improve healthcare efficiency and patient engagement. This acquisition builds on a fruitful collaboration between the involved parties.